Lipoprotein Lipase as a Candidate Target for Cancer Prevention/Therapy

Table 2

Summary of tumor suppressive effects of LPL inducers in animal models.

Agent	Dose	Animal model	Value to the untreated control group	Reference
Pioglitazone	200 ppm	𝐴𝑝𝑐^1309	67%	[59]
	1600 ppm	Min	9%	[60]
	800 ppm	BOP-treated hamster	40%	[63]
NO-1886	800 ppm	Min	42%	[65]
Indomethacin	10 ppm	Min	25%	[66]